Raphael Pharmaceutical Revenue Growth Rates (RAPH), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Raphael Pharmaceutical Inc.  (OTC: RAPH)
 

RAPH's Revenue Growth by Quarter and Year

Raphael Pharmaceutical's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

RAPH Revenue (in millions $) FY 2027 FY 2026 FY 2025 FY 2024
4th Quarter December -
3rd Quarter September -
2nd Quarter June 0.00
1st Quarter March 0.00
FY 0.00





RAPH Revenue second quarter 2027 Y/Y Growth Comment
Raphael Pharmaceutical Inc. in the second quarter 2027 recorded of $ 0.00 millions.

According to the results reported in the second quarter 2027, Raphael Pharmaceutical Inc. achieved the best Revenue growth in Legal Cannabis industry. While Raphael Pharmaceutical Inc.' s Revenue no change of 0% ranks overall at the positon no. in the second quarter 2027.


RAPH Revenue ( Y/Y Growth %) 2027
 2026 2025 2024
4th Quarter December - - - -
3rd Quarter September - - - -
2nd Quarter June - - - -
1st Quarter March - - - -
FY   - - - -

Financial Statements
Raphael Pharmaceutical's second quarter 2027 Revenue $ 0.00 millions RAPH's Income Statement
Raphael Pharmaceutical's second quarter 2026 Revenue $ 0.00 millions Quarterly RAPH's Income Statement


RAPH Revenue (Quarter on Quarter Growth %)

 2027
 2026 2025 2024
4th Quarter December - - - -
3rd Quarter September - - - -
2nd Quarter June - - - -
1st Quarter March - - - -
FY (Year on Year)   - - - -


Back to RAPH Growth rate Comparisons >> Back to RAPH Growth rate Comparisons >>


Revenue second quarter 2027 Y/Y Growth Company Ranking
Within: No.
Legal Cannabis Industry #
Consumer Non Cyclical Sector #
Overall #

Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Revenue second quarter 2027 Y/Y Growth Company Ranking
Within: No.
Legal Cannabis Industry #
Consumer Non Cyclical Sector #
Overall #
Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Revenue by Quarter for the Fiscal Years 2024, 2025, 2026, 2027

Raphael Pharmaceutical's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


RAPH's II. Quarter Q/Q Revenue Comment


Revenue Q/Q Growth Company Ranking
Within: No.
Legal Cannabis Industry #
Consumer Non Cyclical Sector #
Overall #
Revenue Q/Q Growth Company Ranking
Within: No.
Legal Cannabis Industry #
Consumer Non Cyclical Sector #
Overall #
Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


RAPH's II. Quarter Q/Q Revenue Comment


Raphael Pharmaceutical's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)		 12 Months Ending
(Mar 31 2026)		 12 Months Ending
(Dec 31 2025)		 12 Months Ending
(Sep 30 2025)		 12 Months Ending
(Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Revenue Growth (TTM) - - - - -
Year on Year Revenue Growth Overall Ranking # # # # #
Seqeuential Revenue Change (TTM) - - - - -
Seq. Revenue Growth (TTM) Overall Ranking # # # # #


Cumulative Revenue growth Comment
In the Jun 30 2026 period, Raphael Pharmaceutical's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Raphael Pharmaceutical Inc. achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Legal Cannabis Industry #
Consumer Non Cyclical Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
 0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Revenue growth Comment
In the Jun 30 2026 period, Raphael Pharmaceutical's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Raphael Pharmaceutical Inc. achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Legal Cannabis Industry #
Consumer Non Cyclical Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 






Other Revenue Growth
Legal Cannabis Industry Revenue Growth Trends and Statistics
Consumer Non Cyclical Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
RAPH's Revenue Growth Ratio versus Legal Cannabis Industry, Consumer Non Cyclical Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue no change for the quarter ending Jun 30 2026 within Consumer Non Cyclical SectorY/Y Change %Revenue for the quarter ending Jun 30 2026
Tyson Foods Inc -0.12%$ -0.115 millions
Tootsie Roll Industries Inc-0.17%$ -0.171 millions
Ascend Wellness Holdings, Inc.-0.93%$ -0.932 millions
Andersons Inc -1.22%$ -1.218 millions
Scotts Miracle gro Co-1.34%$ -1.338 millions
Kraft Heinz Co-1.42%$ -1.417 millions
Willamette Valley Vineyards Inc -1.56%$ -1.564 millions
Post Holdings Inc -1.83%$ -1.829 millions
The Marzetti Company-2.19%$ -2.187 millions
Smithfield Foods Inc -2.30%$ -2.297 millions
Pilgrim s Pride Corporation-2.76%$ -2.755 millions
The Boston Beer Company Inc -3.34%$ -3.335 millions
Niagen Bioscience Inc -4.28%$ -4.281 millions
Mosaic Co-6.04%$ -6.042 millions
J and j Snack Foods Corp -6.19%$ -6.186 millions
Beyond Meat Inc -7.72%$ -7.721 millions
Central Garden and Pet Company-8.09%$ -8.088 millions
Golden Growers Cooperative-8.38%$ -8.378 millions
American Vanguard Corporation-9.17%$ -9.174 millions
Biote Corp -9.48%$ -9.478 millions
Vital Farms Inc -9.66%$ -9.660 millions
Trulieve Cannabis Corp.-10.31%$ -10.306 millions
Reed s Inc -14.98%$ -14.977 millions
Longevity Health Holdings Inc -21.37%$ -21.370 millions
Solesence Inc -22.87%$ -22.866 millions
Upexi Inc -26.57%$ -26.574 millions
Medifast Inc -27.01%$ -27.006 millions
The Hain Celestial Group Inc -27.60%$ -27.599 millions
22nd Century Group inc -29.86%$ -29.855 millions
Hydrofarm Holdings Group Inc -40.17%$ -40.169 millions


About Raphael Pharmaceutical Revenue Growth Rates (RAPH), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Raphael Pharmaceutical Inc (CIK 1415397).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001213900-26-089975
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Raphael Pharmaceutical Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.